Anaesthetic machine

Last updated

Anaesthetic machine
Maquet Flow-I anesthesia machine.jpg
An anaesthetic machine. This particular machine is a "Flow-I" model, manufactured by Maquet, a division of Getinge Group, Getinge, Sweden.
Process type physical change
Industrial sector(s) anaesthesiology (medicine)
Main technologies or sub-processes vaporization
Feedstock inhalational anaesthetic agents, chiefly nitrous oxide and volatile anaesthetics
Product(s) phase transition of feedstock from the liquid phase to the gas phase
Main facilitieshospitals and outpatient surgery centres

An anaesthetic machine (British English) or anesthesia machine (American English) is a medical device used to generate and mix a fresh gas flow of medical gases and inhalational anaesthetic agents for the purpose of inducing and maintaining anaesthesia. [1]

Contents

The machine is commonly used together with a mechanical ventilator, breathing system, suction equipment, and patient monitoring devices; strictly speaking, the term "anaesthetic machine" refers only to the component which generates the gas flow, but modern machines usually integrate all these devices into one combined freestanding unit, which is colloquially referred to as the "anaesthetic machine" for the sake of simplicity. In the developed world, the most frequent type in use is the continuous-flow anaesthetic machine or "Boyle's machine", which is designed to provide an accurate supply of medical gases mixed with an accurate concentration of anaesthetic vapour, and to deliver this continuously to the patient at a safe pressure and flow. This is distinct from intermittent-flow anaesthetic machines, which provide gas flow only on demand when triggered by the patient's own inspiration.

Simpler anaesthetic apparatus may be used in special circumstances, such as the triservice anaesthetic apparatus, a simplified anaesthesia delivery system invented for the British Defence Medical Services, which is light and portable and may be used for ventilation even when no medical gases are available. This device has unidirectional valves which suck in ambient air, which can be enriched with oxygen from a cylinder, with the help of a set of bellows.

History

The original concept of continuous-flow machines was popularised by Boyle's anaesthetic machine, invented by the British anaesthetist Henry Boyle at St Bartholomew's Hospital in London, United Kingdom, in 1917, although similar machines had been in use in France and the United States. [2] Prior to this time, anaesthesiologists often carried all their equipment with them, but the development of heavy, bulky cylinder storage and increasingly elaborate airway equipment meant that this was no longer practical for most circumstances. Contemporary anaesthetic machines are sometimes still referred to metonymously as "Boyle's machine", and are usually mounted on anti-static wheels for convenient transportation.

Handheld anaesthetic device for trichloroethylene, made in the UK, 1947. This device was designed for self-administration by the patient. Cyprane Trilene inhaler.png
Handheld anaesthetic device for trichloroethylene, made in the UK, 1947. This device was designed for self-administration by the patient.

Many of the early innovations in anaesthetic equipment in the United States, including the closed circuit carbon-dioxide absorber (a.k.a. the Guedel-Foregger Midget) and diffusion of such equipment to anaesthesiologists within the United States can be attributed to Richard von Foregger and The Foregger Company.

Flow rate

In anaesthesia, fresh gas flow is the mixture of medical gases and volatile anaesthetic agents which is produced by an anaesthetic machine and has not been recirculated. The flow rate and composition of the fresh gas flow is determined by the anaesthetist. Typically the fresh gas flow emerges from the common gas outlet, a specific outlet on the anaesthetic machine to which the breathing attachment is connected. [3]

Open circuit forms of equipment, such as the Magill attachment, require high fresh gas flows (e.g. 7 litres/min) to prevent the patient from rebreathing their own expired carbon dioxide. Recirculating (rebreather) systems, use soda lime to absorb carbon dioxide, in the scrubber, so that expired gas becomes suitable to re-use. With a very efficient recirculation system, the fresh gas flow may be reduced to the patient's minimum oxygen requirements (e.g. 250ml/min), plus a little volatile as needed to maintain the concentration of anaesthetic agent.

Increasing fresh gas flow to a recirculating breathing system can reduce carbon dioxide absorbent consumption. There is a cost/benefit trade-off between gas flow and use of adsorbent material when no inhalational anaesthetic agent is used which may have economic and environmental consequences. [3]

Anaesthetic vapouriser

Anesthetic machine, showing sevoflurane (yellow) and isoflurane (purple) vaporizers on the right Vaporizer.jpg
Anesthetic machine, showing sevoflurane (yellow) and isoflurane (purple) vaporizers on the right

An anesthetic vaporizer (American English) or anaesthetic vapouriser (British English) is a device generally attached to an anesthetic machine which delivers a given concentration of a volatile anesthetic agent. It works by controlling the vaporization of anesthetic agents from liquid, and then accurately controlling the concentration in which these are added to the fresh gas flow. The design of these devices takes account of varying: ambient temperature, fresh gas flow, and agent vapor pressure. There are generally two types of vaporizers: plenum and drawover. Both have distinct advantages and disadvantages. [5] The dual-circuit gas-vapor blender is a third type of vaporizer used exclusively for the agent desflurane.

Plenum vaporizers

The plenum vaporizer is driven by positive pressure from the anesthetic machine, and is usually mounted on the machine. The performance of the vaporizer does not change regardless of whether the patient is breathing spontaneously or is mechanically ventilated. The internal resistance of the vaporizer is usually high, but because the supply pressure is constant the vaporizer can be accurately calibrated to deliver a precise concentration of volatile anesthetic vapor over a wide range of fresh gas flows. [5] The plenum vaporizer is an elegant device which works reliably, without external power, for many hundreds of hours of continuous use, and requires very little maintenance.

The plenum vaporizer works by accurately splitting the incoming gas into two streams. One of these streams passes straight through the vaporizer in the bypass channel. The other is diverted into the vaporizing chamber. Gas in the vaporizing chamber becomes fully saturated with volatile anesthetic vapor. This gas is then mixed with the gas in the bypass channel before leaving the vaporizer.

A typical volatile agent, isoflurane, has a saturated vapor pressure of 32kPa (about 1/3 of an atmosphere). This means that the gas mixture leaving the vaporizing chamber has a partial pressure of isoflurane of 32kPa. At sea-level (atmospheric pressure is about 101kPa), this equates conveniently to a concentration of 32%. However, the output of the vaporizer is typically set at 1–2%, which means that only a very small proportion of the fresh gas needs to be diverted through the vaporizing chamber (this proportion is known as the splitting ratio). It can also be seen that a plenum vaporizer can only work one way round: if it is connected in reverse, much larger volumes of gas enter the vaporizing chamber, and therefore potentially toxic or lethal concentrations of vapor may be delivered. (Technically, although the dial of the vaporizer is calibrated in volume percent (e.g. 2%), what it actually delivers is a partial pressure of anesthetic agent (e.g. 2kPa)).

The performance of the plenum vaporizer depends extensively on the saturated vapor pressure of the volatile agent. This is unique to each agent, so it follows that each agent must only be used in its own specific vaporizer. Several safety systems, such as the Fraser-Sweatman system, have been devised so that filling a plenum vaporizer with the wrong agent is extremely difficult. A mixture of two agents in a vaporizer could result in unpredictable performance from the vaporizer.

Saturated vapor pressure for any one agent varies with temperature, and plenum vaporizers are designed to operate within a specific temperature range. They have several features designed to compensate for temperature changes (especially cooling by evaporation). They often have a metal jacket weighing about 5 kg, which equilibrates with the temperature in the room and provides a source of heat. In addition, the entrance to the vaporizing chamber is controlled by a bimetallic strip, which admits more gas to the chamber as it cools, to compensate for the loss of efficiency of evaporation.

The first temperature-compensated plenum vaporizer was the Cyprane 'FluoTEC' Halothane vaporizer, released onto the market shortly after Halothane was introduced into clinical practice in 1956.

Drawover vaporizers

The drawover vaporizer is driven by negative pressure developed by the patient, and must therefore have a low resistance to gas flow. Its performance depends on the minute volume of the patient: its output drops with increasing minute ventilation.

The design of the drawover vaporizer is much simpler: in general it is a simple glass reservoir mounted in the breathing attachment. Drawover vaporizers may be used with any liquid volatile agent (including older agents such as diethyl ether or chloroform, although it would be dangerous to use desflurane). Because the performance of the vaporizer is so variable, accurate calibration is impossible. However, many designs have a lever which adjusts the amount of fresh gas which enters the vaporizing chamber.

The drawover vaporizer may be mounted either way round, and may be used in circuits where re-breathing takes place, or inside the circle breathing attachment.

Drawover vaporizers typically have no temperature compensating features. With prolonged use, the liquid agent may cool to the point where condensation and even frost may form on the outside of the reservoir. This cooling impairs the efficiency of the vaporizer. One way of minimising this effect is to place the vaporizer in a bowl of water.

The relative inefficiency of the drawover vaporizer contributes to its safety. A more efficient design would produce too much anesthetic vapor. The output concentration from a drawover vaporizer may greatly exceed that produced by a plenum vaporizer, especially at low flows. For safest use, the concentration of anesthetic vapor in the breathing attachment should be continuously monitored.

Despite its drawbacks, the drawover vaporizer is cheap to manufacture and easy to use. In addition, its portable design means that it can be used in the field or in veterinary anesthesia.

Dual-circuit gas–vapor blender

The third category of vaporizer (the dual-circuit gas–vapor blender) was created specifically for the agent desflurane. [5] Desflurane boils at 23.5 °C, which is very close to room temperature. This means that at normal operating temperatures, the saturated vapor pressure of desflurane changes greatly with only small fluctuations in temperature. This means that the features of a normal plenum vaporizer are not sufficient to ensure an accurate concentration of desflurane. Additionally, on a very warm day, all the desflurane would boil, and very high (potentially lethal) concentrations of desflurane might reach the patient.

A desflurane vaporizer (e.g. the TEC 6 produced by Datex-Ohmeda) is heated to 39C and pressurized to 194kPa. [6] It is mounted on the anesthetic machine in the same way as a plenum vaporizer, but its function is quite different. It evaporates a chamber containing desflurane using heat, and injects small amounts of pure desflurane vapor into the fresh gas flow. A transducer senses the fresh gas flow. [5]

A warm-up period is required after switching on. The desflurane vaporizer will fail if mains power is lost. Alarms sound if the vaporizer is nearly empty. An electronic display indicates the level of desflurane in the vaporizer.

The expense and complexity of the desflurane vaporizer have contributed to the relative lack of popularity of desflurane, although in recent years it is gaining in popularity.

Historical vaporizers

Historically, ether (the first volatile agent) was first used by John Snow's inhaler (1847) but was superseded by the use of chloroform (1848). Ether then slowly made a revival (1862–1872) with regular use via Curt Schimmelbusch's "mask", a narcosis mask for dripping liquid ether. Now obsolete, it was a mask constructed of wire, and covered with cloth.

Pressure and demand from dental surgeons for a more reliable method of administering ether helped modernize its delivery. In 1877, Clover invented an ether inhaler with a water jacket, and by the late 1899 alternatives to ether came to the fore, mainly due to the introduction of spinal anesthesia. Subsequently, this resulted in the decline of ether (1930–1956) use due to the introduction of cyclopropane, trichloroethylene, and halothane. By the 1980s, the anesthetic vaporizer had evolved considerably; subsequent modifications lead to a raft of additional safety features such as temperature compensation, a bimetallic strip, temperature-adjusted splitting ratio and anti-spill measures.

Components of a typical machine

Simple schematic of an anaesthetic machine Anesthesia machine simple schm.png
Simple schematic of an anaesthetic machine
The adjustable pressure-limiting valve on a General Electric Datex-Ohmeda Aisys anaesthetic machine, with pressure gradations shown in centimetres of water Adjustable pressure-limiting valve anaesthetic machine.jpg
The adjustable pressure-limiting valve on a General Electric Datex-Ohmeda Aisys anaesthetic machine, with pressure gradations shown in centimetres of water

The breathing circuit is the ducting through which the breathing gases flow from the machine to the patient and back, and includes components for mixing, adjusting, and monitoring the composition of the breathing gas, and for removing carbon dioxide.

A modern anaesthetic machine includes at minimum the following components: [2]

Systems for monitoring the patient's heart rate, ECG, blood pressure and oxygen saturation may be incorporated, in some cases with additional options for monitoring end-tidal carbon dioxide and temperature. [2] Breathing systems are also typically incorporated, including a manual reservoir bag for ventilation in combination with an adjustable pressure-limiting valve, as well as an integrated mechanical ventilator, to accurately ventilate the patient during anaesthesia. [2]

Safety features of modern machines

Based on experience gained from analysis of mishaps, the modern anaesthetic machine incorporates several safety devices, including:

The functions of the machine should be checked at the beginning of every operating list in a "cockpit-drill". Machines and associated equipment must be maintained and serviced regularly.

Older machines may lack some of the safety features and refinements present on newer machines. However, they were designed to be operated without mains electricity, using compressed gas power for the ventilator and suction apparatus. Modern machines often have battery backup, but may fail when this becomes depleted.

The modern anaesthetic machine still retains all the key working principles of the Boyle's machine (a British Oxygen Company trade name) in honour of the British anaesthetist Henry Boyle. In India, however, the trade name 'Boyle' is registered with Boyle HealthCare Pvt. Ltd., Indore MP.

Various regulatory and professional bodies have formulated checklists for different countries. [8] Machines should be cleaned between cases as they are at considerable risk of contamination with pathogens. [9]

See also

Related Research Articles

General anaesthetics are often defined as compounds that induce a loss of consciousness in humans or loss of righting reflex in animals. Clinical definitions are also extended to include an induced coma that causes lack of awareness to painful stimuli, sufficient to facilitate surgical applications in clinical and veterinary practice. General anaesthetics do not act as analgesics and should also not be confused with sedatives. General anaesthetics are a structurally diverse group of compounds whose mechanisms encompass multiple biological targets involved in the control of neuronal pathways. The precise workings are the subject of some debate and ongoing research.

<span class="mw-page-title-main">Nitrous oxide</span> Colourless non-flammable greenhouse gas

Nitrous oxide, commonly known as laughing gas, nitrous, factitious air, among others, is a chemical compound, an oxide of nitrogen with the formula N
2
O
. At room temperature, it is a colourless non-flammable gas, and has a slightly sweet scent and taste. At elevated temperatures, nitrous oxide is a powerful oxidiser similar to molecular oxygen.

<span class="mw-page-title-main">Anesthesia</span> State of medically-controlled temporary loss of sensation or awareness

Anesthesia or anaesthesia is a state of controlled, temporary loss of sensation or awareness that is induced for medical or veterinary purposes. It may include some or all of analgesia, paralysis, amnesia, and unconsciousness. An individual under the effects of anesthetic drugs is referred to as being anesthetized.

<span class="mw-page-title-main">Halothane</span> General anaesthetic

Halothane, sold under the brand name Fluothane among others, is a general anaesthetic. It can be used to induce or maintain anaesthesia. One of its benefits is that it does not increase the production of saliva, which can be particularly useful in those who are difficult to intubate. It is given by inhalation.

<span class="mw-page-title-main">Isoflurane</span> General anaesthetic given via inhalation

Isoflurane, sold under the brand name Forane among others, is a general anesthetic. It can be used to start or maintain anesthesia; however, other medications are often used to start anesthesia, due to airway irritation with isoflurane. Isoflurane is given via inhalation.

<span class="mw-page-title-main">Sevoflurane</span> Inhalational anaesthetic

Sevoflurane, sold under the brand name Sevorane, among others, is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset. While its offset may be faster than agents other than desflurane in a few circumstances, its offset is more often similar to that of the much older agent isoflurane. While sevoflurane is only half as soluble as isoflurane in blood, the tissue blood partition coefficients of isoflurane and sevoflurane are quite similar. For example, in the muscle group: isoflurane 2.62 vs. sevoflurane 2.57. In the fat group: isoflurane 52 vs. sevoflurane 50. As a result, the longer the case, the more similar will be the emergence times for sevoflurane and isoflurane.

<span class="mw-page-title-main">General anaesthesia</span> Medically induced loss of consciousness

General anaesthesia (UK) or general anesthesia (US) is a method of medically inducing loss of consciousness that renders a patient unarousable even with painful stimuli. This effect is achieved by administering either intravenous or inhalational general anaesthetic medications, which often act in combination with an analgesic and neuromuscular blocking agent. Spontaneous ventilation is often inadequate during the procedure and intervention is often necessary to protect the airway. General anaesthesia is generally performed in an operating theater to allow surgical procedures that would otherwise be intolerably painful for a patient, or in an intensive care unit or emergency department to facilitate endotracheal intubation and mechanical ventilation in critically ill patients. Depending on the procedure, general anaesthesia may be optional or required. Regardless of whether a patient may prefer to be unconscious or not, certain pain stimuli could result in involuntary responses from the patient that may make an operation extremely difficult. Thus, for many procedures, general anaesthesia is required from a practical perspective.

<span class="mw-page-title-main">Breathing gas</span> Gas used for human respiration

A breathing gas is a mixture of gaseous chemical elements and compounds used for respiration. Air is the most common and only natural breathing gas, but other mixtures of gases, or pure oxygen, are also used in breathing equipment and enclosed habitats. Oxygen is the essential component for any breathing gas. Breathing gases for hyperbaric use have been developed to improve on the performance of ordinary air by reducing the risk of decompression sickness, reducing the duration of decompression, reducing nitrogen narcosis or allowing safer deep diving.

<span class="mw-page-title-main">Anesthetic</span> Drug that causes anesthesia

An anesthetic or anaesthetic is a drug used to induce anesthesia ⁠— ⁠in other words, to result in a temporary loss of sensation or awareness. They may be divided into two broad classes: general anesthetics, which result in a reversible loss of consciousness, and local anesthetics, which cause a reversible loss of sensation for a limited region of the body without necessarily affecting consciousness.

<span class="mw-page-title-main">Desflurane</span> Chemical compound

Desflurane (1,2,2,2-tetrafluoroethyl difluoromethyl ether) is a highly fluorinated methyl ethyl ether used for maintenance of general anesthesia. Like halothane, enflurane, and isoflurane, it is a racemic mixture of (R) and (S) optical isomers (enantiomers). Together with sevoflurane, it is gradually replacing isoflurane for human use, except in economically undeveloped areas, where its high cost precludes its use. It has the most rapid onset and offset of the volatile anesthetic drugs used for general anesthesia due to its low solubility in blood.

<span class="mw-page-title-main">Nitrous oxide (medication)</span> Gas used as anesthetic and for pain relief

Nitrous oxide, as medical gas supply, is an inhaled gas used as pain medication, and is typically administered with 50% oxygen mix. It is often used together with other medications for anesthesia. Common uses include during childbirth, following trauma, and as part of end-of-life care. Onset of effect is typically within half a minute, and the effect lasts for about a minute.

<span class="mw-page-title-main">Inhalational anesthetic</span> Volatile or gaseous anesthetic compound delivered by inhalation

An inhalational anesthetic is a chemical compound possessing general anesthetic properties that is delivered via inhalation. They are administered through a face mask, laryngeal mask airway or tracheal tube connected to an anesthetic vaporiser and an anesthetic delivery system. Agents of significant contemporary clinical interest include volatile anesthetic agents such as isoflurane, sevoflurane and desflurane, as well as certain anesthetic gases such as nitrous oxide and xenon.

<span class="mw-page-title-main">Halogenated ether</span> Subcategory of ether used in anesthesiology

A halogenated ether is a subcategory of a larger group of chemicals known as ethers. An ether is an organic chemical that contains an ether group—an oxygen atom connected to two (substituted) alkyl groups. A good example of an ether is the solvent diethyl ether. What differentiates a halogenated ether from other types of ethers is the substitution (halogenation) of one or more hydrogen atoms with a halogen atom. Halogen atoms include fluorine, chlorine, bromine, and iodine.

Minimum alveolar concentration or MAC is the concentration, often expressed as a percentage by volume, of a vapour in the alveoli of the lungs that is needed to prevent movement in 50% of subjects in response to surgical (pain) stimulus. MAC is used to compare the strengths, or potency, of anaesthetic vapours. The concept of MAC was first introduced in 1965.

<span class="mw-page-title-main">Methoxyflurane</span> Chemical compound

Methoxyflurane, sold under the brand name Penthrox among others, is an inhaled medication primarily used to reduce pain following trauma. It may also be used for short episodes of pain as a result of medical procedures. Onset of pain relief is rapid and of a short duration. Use is only recommended with direct medical supervision.

The Fink effect, also known as "diffusion anoxia", "diffusion hypoxia", or the "second gas effect", is a factor that influences the pO2 (partial pressure of oxygen) within the pulmonary alveoli. When water-soluble gases such as anesthetic agent N2O (nitrous oxide) are breathed in large quantities they can be dissolved in body fluids rapidly. This leads to a temporary increase in both the concentrations and partial pressures of oxygen and carbon dioxide in the alveoli.

A breathing circuit is those parts of a breathing apparatus, which direct the flow of supplied breathing gas to, and sometimes from, the user. The breathing circuit may be open, closed, or semi-closed, depending on whether breathing gas is recycled. A closed or semi-closed circuit will include components which remove carbon dioxide from the exhaled gas and add oxygen before it is delivered for inhalation, so that the mixture remains stable and suitable for supporting life. Terminology may vary slightly between fields of application. In diving and industrial rebreathers, the closed or semi-closed breathing circuit may also be called the loop, or breathing loop. In medical equipment the closed or semi-closed circuit may be called the circle system.

Gas blending is the process of mixing gases for a specific purpose where the composition of the resulting mixture is defined, and therefore, controlled. A wide range of applications include scientific and industrial processes, food production and storage and breathing gases.

Nitrous oxide, desflurane, and isoflurane are the most commonly used anesthetic gases. They may cause some complications due to their leakage and storage failure.

<span class="mw-page-title-main">Inhalation sedation</span>

Inhalation sedation is a form of conscious sedation where an inhaled drug should:

  1. Depress the central nervous system (CNS) to an extent that surgeons can operate with minimal physiological and psychological stress to the patient
  2. Modify the patient's state of mind such that communication is maintained and the patient can respond to verbal command
  3. Carry a margin of safety wide enough to render the unintended loss of consciousness and loss of protective reflexes unlikely.

References

  1. Gurudatt C (September 2013). "The basic anaesthesia machine". Indian J Anaesth. 57 (5): 438–45. doi: 10.4103/0019-5049.120138 . PMC   3821260 . PMID   24249876.
  2. 1 2 3 4 Steven M. Yentis, Nicholas P. Hirsch, James K. Ip (2013). "Anaesthetic machine". Anaesthesia and Intensive Care A–Z: An Encyclopaedia of Principles and Practice. Elsevier Health Sciences. p. 34. ISBN   978-0-7020-4420-5.
  3. 1 2 Zhong G, Abbas A, Jones J, Kong S, McCulloch T (November 2020). "Environmental and economic impact of using increased fresh gas flow to reduce carbon dioxide absorbent consumption in the absence of inhalational anaesthetics". British Journal of Anaesthesia. 125 (5): 773–778. doi: 10.1016/j.bja.2020.07.043 . PMID   32859360.
  4. "What and Why of Low Flow Anesthesia". clinicalview.gehealthcare.com. July 2020. Retrieved 12 October 2023.
  5. 1 2 3 4 Chakravarti S, Basu S (September 2013). "Modern anaesthesia vapourisers". Indian J Anaesth. 57 (5): 464–71. doi: 10.4103/0019-5049.120142 . PMC   3821263 . PMID   24249879.
  6. Boumphrey S, Marshall N (2011). "Understanding vaporizers". Continuing Education in Anaesthesia Critical Care & Pain. 11 (6). Elsevier BV: 199–203. doi: 10.1093/bjaceaccp/mkr040 . ISSN   1743-1816.
  7. Baha Al-Shaikh, Simon Stacey (2013). "Breathing systems". Essentials of Anaesthetic Equipment. Elsevier Health Sciences. pp. 55–73. ISBN   978-0-7020-4954-5.
  8. "International Anesthesia Equipment Checkout Recommendations - Virtual Anesthesia Machine".
  9. Baillie JK, P. Sultan, E. Graveling, C. Forrest, C. Lafong (2007). "Contamination of anaesthetic machines with pathogenic organisms". Anaesthesia. 62 (12): 1257–61. doi: 10.1111/j.1365-2044.2007.05261.x . PMID   17991263. S2CID   24338540.

Further reading